urea has been researched along with ristocetin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (62.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Howard, MA | 1 |
Nieto, M; Perkins, HR | 1 |
Finlay, TH; Kowalski, S; Marcus, DL; Silber, P | 1 |
Hackett, T; Kelton, JG; Powers, P | 1 |
THERIAULT, RJ | 1 |
De Cristofaro, R; Di Stasio, E; Lavoretano, S; Lombardi, R; Mannucci, PM; Merati, G; Palla, R; Peyvandi, F; Romitelli, F | 1 |
Bailey, CL; Chandhoke, V; Chung, MC; Dong, L; Jorgensen, SC; Popov, SG; Popova, TG | 1 |
Handa, M; Ikeda, Y; Okamura, Y; Watanabe, N; Yoshida, H | 1 |
2 review(s) available for urea and ristocetin
Article | Year |
---|---|
The chemical basis for the action of the vancomycin group of antibiotics.
Topics: Bacteria; Bacterial Proteins; Cell Membrane; Cell Wall; Cell-Free System; Chemical Phenomena; Chemistry; Drug Stability; Hydrogen-Ion Concentration; Iodine Radioisotopes; Peptide Biosynthesis; Peptides; Peptidoglycan; Potassium Chloride; Protein Binding; Protoplasts; Ristocetin; Sodium Dodecyl Sulfate; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Urea; Vancomycin | 1974 |
Drug-induced platelet destruction.
Topics: Binding Sites, Antibody; Blood Platelets; Cell Differentiation; Cell Migration Inhibition; Clot Retraction; Complement Fixation Tests; Gold; Heparin; Humans; Immunoglobulin G; Intradermal Tests; Platelet Aggregation; Platelet Factor 3; Prednisone; Quinidine; Ristocetin; Serotonin; Thrombocytopenia; Thromboembolism; Urea; Valproic Acid | 1982 |
6 other study(ies) available for urea and ristocetin
Article | Year |
---|---|
Inhibition and reversal of ristocetin - induced platelet aggregation.
Topics: Animals; Blood Platelets; Factor VIII; Heparin; Humans; Hydrogen-Ion Concentration; Immune Sera; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Ristocetin; Thrombin; Urea | 1975 |
Interaction of porcine von Willebrand factor (platelet aggregating factor) with human platelets.
Topics: Animals; Antibodies; Blood Coagulation Factors; Blood Platelets; Electrophoresis, Polyacrylamide Gel; Humans; In Vitro Techniques; Kinetics; Osmolar Concentration; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Ristocetin; Swine; Urea; von Willebrand Factor | 1981 |
HETEROTROPHIC GROWTH AND PRODUCTION OF XANTHOPHYLLS BY CHLORELLA PYRENOIDOSA.
Topics: Animals; Anti-Bacterial Agents; Bioreactors; Carbohydrate Metabolism; Carbon; Chickens; Chlorella; Culture Media; Equipment and Supplies; Erythromycin; Eukaryota; Fermentation; Glucose; Heterotrophic Processes; Lutein; Metabolism; Neomycin; Penicillins; Pharmacology; Polymyxins; Research; Ristocetin; Spectrophotometry; Tetracycline; Urea; Xanthophylls | 1965 |
Role of chloride ions in modulation of the interaction between von Willebrand factor and ADAMTS-13.
Topics: ADAM Proteins; ADAMTS13 Protein; Anti-Bacterial Agents; Cell Line; Cell Membrane; Chlorides; Electrophoresis, Polyacrylamide Gel; Humans; Hydrogen-Ion Concentration; Hydrolysis; Ions; Kinetics; Metalloendopeptidases; Protein Binding; Protein Conformation; Recombinant Proteins; Ristocetin; Salts; Sodium Chloride; Spectrometry, Fluorescence; Spectrophotometry; Time Factors; Transfection; Tyrosine; Ultraviolet Rays; Urea; von Willebrand Factor | 2005 |
Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
Topics: ADAM Proteins; ADAMTS13 Protein; Animals; Anthrax; Anti-Bacterial Agents; Bacterial Proteins; Blood Platelets; Cell Communication; Collagen; Disease Models, Animal; Disseminated Intravascular Coagulation; Endothelial Cells; Hemostasis; Humans; Leukopenia; Metalloendopeptidases; Metalloproteases; Mice; Plasma; Platelet Aggregation; Protein Binding; Protein Structure, Tertiary; Ristocetin; Spores, Bacterial; Substrate Specificity; Thrombocytopenia; Thrombosis; Time Factors; Urea; von Willebrand Factor | 2008 |
Shear-dependent suppression of platelet thrombus formation by phosphodiesterase 3 inhibition requires low levels of concomitant Gs-coupled receptor stimulation.
Topics: Aspirin; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits, Gs; Hemostasis; Humans; Ligands; Platelet Aggregation; Quinolines; Ristocetin; Shear Strength; Tirofiban; Tyrosine; Urea; von Willebrand Factor | 2011 |